The British Association for Psychopharmacology just released a consensus statement on evidence-based treatment of insomnia, parasomnias, and circadian rhythm disorders.
The British Association for Psychopharmacology (BAP) released yesterday, through the Journal of Psychopharmacology, a consensus statement on evidence-based treatment of insomnia, parasomnias, and circadian rhythm disorders, meant to guide psychiatrists and other physicians who care for patients with sleep problems.
Members of BAP and sleep experts for the US and Europe convened in London in May 2009 to share their knowledge, experiences, and the latest literature and come to a consensus on best treatments. The BAP used the consensus information and follow-up consultations with participants to create the comprehensive guide to clinicians.
Key points made in the consensus statement include the following:
More on Insomnia in the News: